National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting, 20756 [05-7991]

Download as PDF 20756 Federal Register / Vol. 70, No. 76 / Thursday, April 21, 2005 / Notices Name: Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) and Subcommittee for Dose Reconstruction and Site Profile Reviews. Subcommittee Meeting Time and Date: 8 a.m.–11:30 a.m., April 25, 2005. Committee Meeting Times and Dates: 1 p.m.–6:15 p.m., April 25, 2005. 8 a.m.–5:15 p.m., April 26, 2005. 7 p.m.–8:30 p.m., April 26, 2005. 8 a.m.–5:30 p.m., April 27, 2005. Place: Crowne Plaza Five Seasons Hotel, 350 1st Avenue Northeast, Cedar Rapids, Iowa 52401, telephone (319) 363–8161, fax (319) 363–3804. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 200 people. Background: The ABRWH was established under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA) of 2000 to advise the President, delegated to the Secretary of Health and Human Services (HHS), on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Board include providing advice on the development of probability of causation guidelines which have been promulgated by HHS as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, and renewed on August 3, 2003. Purpose: This board is charged with (a) Providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS on the scientific validity and quality of dose reconstruction efforts performed for this Program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters to be Discussed: Agenda for this meeting will focus on Review of the Draft Minutes; Iowa Army Ammunition Plant Technical Basis Document and Special Exposure Cohort (SEC) Petition; Mallinckrodt (Destrehan Street Facility) Technical Basis Document and SEC Petition; Program updates by NIOSH and DOL; Future Schedule; Policy Concerning Data Integrity; Board Operating Procedures; Discussion of first 20 Dose Reconstruction Reviews; SEC Task for SC&A, Inc.; and SC&A, Inc. Contract Update Status. There will be an evening VerDate jul<14>2003 14:55 Apr 20, 2005 Jkt 205001 public comment period scheduled for April 26, 2005 and general public comment periods during the day on April 25th and 27th. The Subcommittee will convene on April 25, 2005, from 8 a.m.–11:30 a.m. and will focus on review of draft minutes; Report on the Review of the First 20 Dose Reconstructions; the process to accomplish review of SC&A Task III Report; Status Report of On-Going Activities and Future Schedule; as well as Comments by Members of Congress. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below well in advance of the meeting. Contact Person for More Information: Dr. Lewis V. Wade, Executive Secretary, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, Ohio 45226, telephone (513) 533–6825, fax (513) 533–6826. This notice is being published less than 15 days prior to the meeting due to the unexpected urgency of the topics that will be discussed. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 18, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–8088 Filed 4–19–05; 12:27 pm] BILLING CODE 4163–19–P U.S.C. 280f, as added by Public Law 105– 392) to establish a National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect to: (1) Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effect (FAE) research, programs and surveillance; and (2) to otherwise meet the general needs of populations actually or potentially impacted by FAS and FAE. Matters to be Discussed: Agenda items include: Prevention and Post-Exposure working group sessions; updates on progress of Task Force working groups; discussion of future activities to promote the Surgeon General’s Advisory; updates from the Interagency Coordinating Committee on Fetal Alcohol Syndrome, the CDC and other Federal agencies, and liaison members; future meeting topics; and scheduling of the next meeting. Agenda items are subject to change as priorities dictate. For Further Information Contact: Mary Kate Weber, M.P.H., Designated Federal Official, National Center on Birth Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E–86), Atlanta, Georgia 30333, telephone 404/498–3926, fax 404/ 498–3550. The Director, Management and Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 14, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–7991 Filed 4–20–05; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Federal advisory committee meeting. Name: National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE). Times and Dates: 8:30 a.m.–4:30 p.m., June 15, 2005. 8:30 a.m.–12 noon, June 16, 2005. Place: Doubletree Hotel Atlanta/Buckhead, 3342 Peachtree Road, NE., 30326, telephone 404/231–1234, fax 404/231–3112. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 65 people. Purpose: The Secretary is authorized by the Public Health Service Act, Section 399G, (42 Agency for Toxic Substances and Disease Registry Public Meeting of the Citizens Advisory Committee on Public Health Service Activities and Research at Department of Energy (DOE) Sites: Oak Ridge Reservation Health Effects Subcommittee Name: Public meeting of the Citizens Advisory Committee on PHS Activities and Research at DOE Sites: Oak Ridge Reservation Health Effects Subcommittee (ORRHES). Time and Date: 12 p.m.–2 p.m., May 3, 2005. Place: ATSDR/Oak Ridge Field Office, 197 South Tulane, Oak Ridge, TN. Telephone: (865) 220–0295. Participants may participate via phone. PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 70, Number 76 (Thursday, April 21, 2005)]
[Notices]
[Page 20756]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7991]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol 
Effect: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meeting.

    Name: National Task Force on Fetal Alcohol Syndrome and Fetal 
Alcohol Effect (NTFFASFAE).
    Times and Dates: 8:30 a.m.-4:30 p.m., June 15, 2005. 8:30 a.m.-
12 noon, June 16, 2005.
    Place: Doubletree Hotel Atlanta/Buckhead, 3342 Peachtree Road, 
NE., 30326, telephone 404/231-1234, fax 404/231-3112.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 65 people.
    Purpose: The Secretary is authorized by the Public Health 
Service Act, Section 399G, (42 U.S.C. 280f, as added by Public Law 
105-392) to establish a National Task Force on Fetal Alcohol 
Syndrome and Fetal Alcohol Effect to: (1) Foster coordination among 
all governmental agencies, academic bodies and community groups that 
conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol 
Effect (FAE) research, programs and surveillance; and (2) to 
otherwise meet the general needs of populations actually or 
potentially impacted by FAS and FAE.
    Matters to be Discussed: Agenda items include: Prevention and 
Post-Exposure working group sessions; updates on progress of Task 
Force working groups; discussion of future activities to promote the 
Surgeon General's Advisory; updates from the Interagency 
Coordinating Committee on Fetal Alcohol Syndrome, the CDC and other 
Federal agencies, and liaison members; future meeting topics; and 
scheduling of the next meeting.
    Agenda items are subject to change as priorities dictate.
    For Further Information Contact: Mary Kate Weber, M.P.H., 
Designated Federal Official, National Center on Birth Defects and 
Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E-86), 
Atlanta, Georgia 30333, telephone 404/498-3926, fax 404/498-3550.
    The Director, Management and Analysis and Services office has 
been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee 
management activities for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

    Dated: April 14, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-7991 Filed 4-20-05; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.